Novocure Ltd sell geldnutzer
Start price
09.01.22
/
70%
€59.26
Target price
09.01.23
€51.00
Performance (%)
8.34%
End price
16.03.22
€64.20
Summary
This prediction ended on 16.03.22 with a price of €64.20. The SELL prediction by geldnutzer shows the price for Novocure Ltd slightly increased by 8.34% during the runtime of the prediction. geldnutzer has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Novocure Ltd | 25.795% | 25.795% | -76.180% |
iShares Core DAX® | 2.831% | 1.236% | 14.788% |
iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% |
iShares Nikkei 225® | 2.007% | -2.135% | 19.861% |
iShares S&P 500 | 2.257% | 0.451% | 30.090% |
According to geldnutzer what are the pros and cons of Novocure Ltd for the foreseeable future?
Pros
Innovative
Stable Large shareholder and/or long term investor
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
very negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Unknown brand
Business model of the past or high risk
Comments by geldnutzer for this prediction
In the thread Novocure Ltd diskutieren
Sell mit Kursziel 51,0
In the thread Trading Novocure Ltd
Sell beendet
Stopped prediction by geldnutzer for Novocure Ltd
Novocure Ltd
Start price
Target price
Perf. (%)
€64.20
16.03.22
16.03.22
€68.00
16.03.23
16.03.23
-6.99%
17.03.23
17.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group